BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes
When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...
Tag: GSK
GSK pays $500M for rights to drugs from Chinese firm Hengrui
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — ...
Spero, GSK, Eli Lilly, Rocket, Novavax
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Novo, GSK, CRISPR, Prime, COPD
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Eli Lilly, Novo Nordisk, FDA, Makary, GSK
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from Flagship-Founded Vesalius
Success rates in drug research for common diseases is low, and one reason for that could be perspective. Science has ...
Pfizer, Starboard, GSK, Medicare news
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. ...
GSK, Flagship Pioneering Commit $150M to Start R&D Pact for Novel Drugs and Vaccines
GSK already has a strong presence in respiratory disease and immunology, two of its core therapeutic areas. The pharmaceutical giant ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!